Acceptance and compliance of TTFields treatment among high grade glioma patients.
Julia OnkenFranziska Staub-BarteltPeter VajkoczyMartin MischPublished in: Journal of neuro-oncology (2018)
TTFields are effective in newly diagnosed GBM, therefore acceptance and compliance is important for GBM treatment. We experienced moderate acceptance rate for TTFields, which is influenced by factors such as social support, comorbidities and independence in daily life. Overall therapy compliance lies above 75% and is not influenced by age, sex, stage of disease or duration of therapy. Improved patient consultation strategies will increase acceptance and compliance for better outcome.